反応 #1244254

ord-464a7899678d4d34b2c447cb9e864b86

反応方程式

CNc1ccc(C=Cc2ccc(OCCOCCO)cc2)cc1
Compound 3a
CNc1ccc(C=Cc2ccc(OCCOCCO)cc2)cc1
2-(2-{4-[2-(4-Methylamino-phenyl)-vinyl]-phenoxy}-ethoxy)-ethanol
CC(C)(C)[Si](C)(C)Cl
TBDMSCl
c1c[nH]cn1
imidazole
CNc1ccc(C=Cc2ccc(OCCOCCO[Si](C)(C)C(C)(C)C)cc2)cc1
7a
収率 93.5%
CNc1ccc(C=Cc2ccc(OCCOCCO[Si](C)(C)C(C)(C)C)cc2)cc1
{4-[2-(4-{2-[2-(tert-Butyl-dimethyl-silanyloxy)-ethoxy]-ethoxy}-phenyl)-vinyl]-phenyl}-methyl-amine
収率 93.5%

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他After standard workup with dichloromethane, the residue was purified by silica gel column chromatography (1.5% methanol in dichloromethane)

実験手順

Compound 3a (45 mg, 0.14 mmol) and TBDMSCl (33 mg, 0.22 mmol) were dissolved in dichloromethane (10 ml) followed by imidazole (20 mg, 0.29 mmol). The solution was stirred at room temperature for 2 hours. After standard workup with dichloromethane, the residue was purified by silica gel column chromatography (1.5% methanol in dichloromethane) to afford 7a (56 mg, 91%): 1H NMR δ 7.40 (m, 4H), 6.90 (m, 4H), 6.75 (d, 2H, J=7.9 Hz), 4.15 (t, 2H), 3.88 (t, 2H), 3.82 (t, 2H), 3.66 (t, 2H), 2.85 (s, 3H), 0.92 (s, 9H), 0.09 (s, 6H).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07807135B2uspto-grants-2010_10